retatrutide clinical trials sign up trial dosing retatrutide Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Trial Data Dosing Schedule : – Find Lilly Clinical Trials

These are generally mild and transient, resolving within a few days without specific treatment

The mean reduction in body weight at 48 weeks was 24.2% in the 12-mg group the largest reduction observed to date in a Phase 2 trial of an anti-obesity medication. Jastreboff et al., New England Journal of Medicine, 2023 The Liver-Fat Result Beyond weight loss, retatrutide produced a result that surprised researchers: dramatic reductions in liver fat

Holter, M

The exception is the 8mg and 12mg doses, which require 160 and 240 units respectively, both exceeding a 1mL syringe capacity

Similarly, those switching from Zepbound to orforglipron experienced a 2.6 kg gain versus a 9.1 kg gain for placebo

Knowing this timeline helps users push through difficult periods rather than abandoning treatment prematurely